Intraocular lens exchange in patients with negative dysphotopsia symptoms.
OBJECTIVE
to evaluate the results of intraocular lens (IOL) exchange in cases of severe negative dysphotopsia and to measure the distance between the iris and the IOL optic using ultrasound biomicroscopy (UBM).


METHODS
Szent Rókus Hospital and Eye Clinic, Semmelweis University, Budapest, Hungary.


METHODS
Data of patients with major negative dysphotopsia symptoms after phacoemulsification with IOL implantation were reviewed retrospectively. In cases in which IOL exchange was performed to diminish the symptoms, the distance between the iris and the anterior surface of the IOL optic was measured by UBM and compared with that in a group of nonsymptomatic pseudophakic patients (control group).


RESULTS
in 3806 cataract procedures, 5 eyes (4 patients) had severe negative dysphotopsia symptoms. Intraocular lens exchange was performed in 3 cases. In 1 case, the secondary IOL was implanted in the reopened capsular bag and the symptoms persisted. In 2 cases, the secondary IOL was implanted in the ciliary sulcus and the symptoms resolved. On UBM, the mean iris-optic distance was 0.45 mm +/- 0.07 (SD) in the symptomatic group, 0.59 +/- 0.29 mm in the control group (n = 21) (P = .353), and 0.00 mm in the sulcus-fixated group.


CONCLUSIONS
The iris-optic distance was not statistically significantly different between eyes with severe negative dysphotopsia symptoms and nonsymptomatic eyes. However, when IOL exchange reduced the iris-IOL distance, the severe negative dysphotopsia symptoms resolved.
Vámosi
Péter
P
Department of Ophthalmology, Szent Rókus Hospital, Semmelweis University, Budapest H-1085, Hungary. vamosipeter@freemail.hu
Csákány
Béla
B
Németh
János
J
D000368:Aged; D000869:Anterior Eye Segment / Q000000981:diagnostic imaging; D020878:Device Removal; D005260:Female; D006801:Humans; D019654:Lens Implantation, Intraocular; D007910:Lenses, Intraocular; D008297:Male; D033401:Microscopy, Acoustic; D008875:Middle Aged; D018918:Phacoemulsification / Q000009:adverse effects*; D019591:Pseudophakia / Q000503:physiopathology; D012086:Reoperation; D014786:Vision Disorders / Q000209:etiology* / Q000503:physiopathology / Q000601:surgery*; D014792:Visual Acuity / Q000502:physiology